About
Augma Biomaterials Ltd. specializes in developing and manufacturing advanced bone grafting materials for maxillofacial and dental surgery. The company focuses on bone substitutes that support various augmentation procedures, including socket grafting and sinus lifts. Their core products, 3D Bond™ and Bond Apatite®, are self-reinforced bone graft cements made from highly pure Biphasic Calcium Sulfate. These materials offer improved moldability and accelerated setting times, making them suitable for a range of dental applications. Bond Apatite® is recognized for its bioactive properties, promoting true bone regeneration. In addition to their products, Augma Biomaterials provides clinical support and educational programs for dental professionals. They offer access to bone cement experts for case consultations and provide accredited continuing education courses, including hands-on training sessions. The company is registered in the UK and is dedicated to enhancing patient outcomes in bone augmentation procedures through innovative solutions and professional education.
Technologies
Keywords
Company Information
-
Employees 14
-
Founded 2009
-
Annual Revenue $4400000
Location
407 Main St, Spotswood, New Jersey, United States, 08884-1701
